BIOPHYTIS (ALBPS.PA) Stock Overview
EPA:ALBPS - FR001400OLP5 - Common Stock
ALBPS.PA Key Statistics, Chart & Performance
The current stock price of ALBPS.PA is 0.1736 EUR. In the past month the price decreased by -2.8%. In the past year, price decreased by -66.6%.
ALBPS.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 19.91 | 319.75B | ||
| 1ABBV.MI | ABBVIE INC | 19.56 | 314.09B | ||
| AMG.DE | AMGEN INC | 12.85 | 129.61B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 14.76 | 121.80B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.74 | 121.61B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 23.31 | 86.90B | ||
| ARGX.BR | ARGENX SE | 86.23 | 39.16B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 23.37B | ||
| IDP.DE | BIOGEN INC | 8.84 | 17.81B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.26B | ||
| 0QF.DE | MODERNA INC | N/A | 8.25B | ||
| 1EXAS.MI | EXACT SCIENCES CORP | N/A | 7.29B |
Related stock screener links
About ALBPS.PA
Company Profile
Biophytis SA operates as a clinical-stage biotechnology company. The company is headquartered in Paris, Ile-De-France and currently employs 18 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Company Info
BIOPHYTIS
14 avenue de l'Opera
Paris ILE-DE-FRANCE FR
Employees: 22
Phone: 33141836600
BIOPHYTIS / ALBPS.PA FAQ
What is the stock price of BIOPHYTIS today?
The current stock price of ALBPS.PA is 0.1736 EUR. The price decreased by -0.23% in the last trading session.
What is the ticker symbol for BIOPHYTIS stock?
The exchange symbol of BIOPHYTIS is ALBPS and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALBPS.PA stock listed?
ALBPS.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for BIOPHYTIS stock?
7 analysts have analysed ALBPS.PA and the average price target is 0.79 EUR. This implies a price increase of 352.42% is expected in the next year compared to the current price of 0.1736. Check the BIOPHYTIS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOPHYTIS worth?
BIOPHYTIS (ALBPS.PA) has a market capitalization of 1.99M EUR. This makes ALBPS.PA a Nano Cap stock.
How many employees does BIOPHYTIS have?
BIOPHYTIS (ALBPS.PA) currently has 22 employees.
What are the support and resistance levels for BIOPHYTIS (ALBPS.PA) stock?
BIOPHYTIS (ALBPS.PA) has a support level at 0.17 and a resistance level at 0.2. Check the full technical report for a detailed analysis of ALBPS.PA support and resistance levels.
Should I buy BIOPHYTIS (ALBPS.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALBPS.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALBPS.PA, evaluating the profitability, health, valuation and growth aspects
- BIOPHYTIS (ALBPS.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOPHYTIS (ALBPS.PA) Sales and EPS estimates to see what analysts future expectations are.
- BIOPHYTIS (ALBPS.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOPHYTIS (ALBPS.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOPHYTIS (ALBPS.PA) Stock Chart to make your own analysis
- BIOPHYTIS (ALBPS.PA) Latest news and press-releases to stay up to date.
Does BIOPHYTIS (ALBPS.PA) stock pay dividends?
ALBPS.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIOPHYTIS (ALBPS.PA)?
BIOPHYTIS (ALBPS.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.54).
ALBPS.PA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ALBPS.PA. When comparing the yearly performance of all stocks, ALBPS.PA is a bad performer in the overall market: 95.4% of all stocks are doing better.
ALBPS.PA Financial Highlights
Over the last trailing twelve months ALBPS.PA reported a non-GAAP Earnings per Share(EPS) of -6.54. The EPS decreased by -8080.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -172.99% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALBPS.PA Forecast & Estimates
7 analysts have analysed ALBPS.PA and the average price target is 0.79 EUR. This implies a price increase of 352.42% is expected in the next year compared to the current price of 0.1736.